Latest Medication News

  • For more information on all medications available in UMMC, please click here.
  • For procedures on how to request to include medication into UMMC's Formulary, please click here.
  • All displayed images are for illustration purpose only.

Waktu Operasi Baru bagi PharmUMMC

posted Mar 26, 2020, 12:18 AM by Rafidah binti Abd Rahim   [ updated Mar 26, 2020, 12:18 AM ]

26 Mac 2020 (Pekeliling No. SPJF: 10/2020)

Berikutan penjadualan semula perkhidmatan Ambulatori dalam menghadapi isu Covid-19, waktu operasi di PharmUMMC dipendekkan selama 1 jam mulai 26 Mac 2020 sehingga diberitahu kelak.

Isnin hingga Jumaat                                          : 7.30 am - 7.00 pm

Sabtu                                                                 : 9.00 am - 1.00 pm

Ahad / Cuti Umum                                             : Tutup

Medication brand and strength change: Theophylline

posted Feb 25, 2020, 7:27 PM by Rafidah binti Abd Rahim   [ updated Mar 26, 2020, 12:19 AM ]

7 February 2020 (Circular No. SP PPUM: 39/2020)



Please be informed that Pharmacy Department has replaced the brand for the APO-Theophylline SR 200mg Tablet to Pharmaniaga Theophylline IR 125mg Tablet.
 

Product Name

:

Theophylline IR 125mg

Active Ingredient

:

Theophylline

Dosage Form

:

Tablet

Registration No.

:

MAL19872133AZ

Holder

:

Pharmaniaga Berhad

Manufacturer

:

Pharmaniaga

Formulary Category

:

Standard

Prescriber

:

All



Dosage conversion:

Theophylline SR 200mg OD = Theophylline IR 125mg BD
Theophylline SR 200mg BD = Theophylline IR 250mg BD

Product Recall: Hydralazine Hydrochloride 20mg/ml injection

posted Feb 25, 2020, 6:00 PM by Rafidah binti Abd Rahim   [ updated Mar 26, 2020, 12:19 AM ]

21 February 2020 (Circular No. SP PPUM: 51/2020)

Product Name

:

Hydralazine Hydrochloride 20mg/ml injection

Active Ingredient

:

Hydralazine

Strength

:

20mg/ml

Dosage Form

:

Injection

Manufacturer

:

Ciron Drugs & Pharmaceuticals PVT.LTD.India

Formulary Category

:

Standard Formulary

Product Registration Number

:

MAL10053652AZ

Batch Number

:

(i)    8EB04439 , MFG : 11/2018, EXP : 10/2020

(ii)   9EB16157 , MFG : 04/2019, EXP : 03/2021

(iii)  9EB18367 , MFG : 10/2019, EXP : 09/2021


Please be informed that Zulat Pharmacy Sdn. Bhd., the distributor of this product, has issued notice of product recall for the particular batch numbers 8EB04439, 9EB16157, and 9EB18367 due to precipitation found in the affected ampules. The use of this product should be stopped immediately.

Therefore, all clinical areas keeping the stocks for this product are required to do prompt checking on the batch number of the current stocks. Kindly segregate the affected stocks according to the batch number and send to Inpatient Pharmacy for exchange of stocks.

Medication Supply Disruption: Etomidate Injection

posted Jan 12, 2020, 10:18 PM by Chong Ching Wern   [ updated Jan 12, 2020, 10:19 PM ]

9 January 2020 (Circular No. SP PPUM: 8/2020)

The following medication will be facing supply disruption:

Product Name

:

Etomidate-Lipuro

Active Ingredient

:

Etomidate

Strength

:

2mg/mL (10mL)

Dosage Form

:

Injection

Registration No.

:

MAL20033662AZ

Holder

:

B Braun Medical Supplies Sdn. Bhd.

Manufacturer

:

B Braun

Cause

:

Production issues by the company.

Estimated Stock Recovery

:

March 2020


Doctors are advised to prescribe Propofol 200mg/20mL Injection as the alternative to this for now.

Medication Strength Change: Deferasirox

posted Nov 12, 2019, 6:35 PM by Muhammad Fikree Ahmad   [ updated Nov 12, 2019, 6:36 PM ]

6 November 2019 (Circular No. SP PPUM: 460/2019)

Please be informed that Novartis Corporation (Malaysia) Sdn. Bhd. has ceased the production of Deferasirox 500mg Dispersible Tablet (Exjade) and replaced the product to Deferasirox 360mg Film-Coated Tablet (Exjade).




Product Name

:

Exjade

Active Ingredient

:

Deferasirox

Strength

:

360mg

Dosage Form

:

Tablet

Product Registration Number

:

MAL18016071ARZ

Manufacturer

:

Novartis

Formulary Category

:

Special Formulary

Prescriber

:

Haematologist

Product Recall: Lactulose 3.3g/5ml Solution

posted Nov 3, 2019, 10:54 PM by Muhammad Fikree Ahmad   [ updated Nov 3, 2019, 10:55 PM ]

4th November 2019 (Circular No. SP PPUM:   456/2019): 


Product Name

:

Unilac Lactulose 3.3g/5ml Oral Solution USP

Active Ingredient

:

Lactulose

Strength

:

3.3g/5ml

Dosage Form

:

Solution

Manufacturer

:

KCK Pharmaceutical Industries Sdn. Bhd.

Formulary Category

:

Standard Formulary

Product Registration Number

:

MAL17015016XZ

Batch Number

:

L1906001


Please be informed that M.S. Ally Pharma Sdn. Bhd., the distributor of this product, has issued notice of product recall for the particular batch number L1906001 due to discoloration (yellowish) of the batch on the contrary to the previous ones (clear and colourless)The use of this product should be stopped immediately.

Therefore, all clinical areas keeping the stocks for this product are required to do prompt checking on the batch number of the current stocks. Kindly segregate the affected stocks according to the batch number and send to Inpatient Pharmacy for exchange of stocks.

Product Recall: Ranitidine 150 mg & 300 mg Tablets

posted Nov 3, 2019, 10:20 PM by Muhammad Fikree Ahmad   [ updated Nov 3, 2019, 10:20 PM ]

29th October 2019 (Circular No. SP PPUM:   451/2019): 


Product Name

:

Pharmaniaga Ranitidine

Active Ingredient

:

Ranitidine

Strength

:

150 mg & 300 mg

Dosage Form

:

Tablet

Manufacturer

:

Pharmaniaga Manufacturing Berhad

Product Registration Number

:

MAL19987368AZ

MAL19987370AZ

Batch Number

:

All batches manufactured within October 2016 to September 2019


Please be informed that Pharmaniaga Manufacturing Berhad, the distributor of this product, has been given notice of product recall due to the adulterated active ingredient. The use of this product should be stopped immediately.

Therefore, all clinical areas keeping the stocks for this product are required segregate the affected stocks and send to Inpatient Pharmacy for disposal purpose. Doctors are advised to prescribe Famotidine 20 mg Tablet as alternative.

Product Recall: Modified Fluid Gelatin 4% Injection (Infusol SG)

posted Nov 3, 2019, 9:04 PM by Muhammad Fikree Ahmad   [ updated Feb 25, 2020, 7:33 PM by Rafidah binti Abd Rahim ]

24th October 2019 (Circular No. SP PPUM:   447/2019): 


Product Name

:  Modified Fluid Gelatin 4% Injection (Infusol SG)

Dosage Form

:  Injection

Manufacturer

:  Ain Medicare Sdn Bhd

Formulary Category

:  Standard Formulary

Batch Number

:  P390A262

Product Registration Number

:  MAL12085086XZ

Reason for Recall

:  Failure to pass bacterial endotoxin test


Please be informed that Ain Medicare Sdn Bhd, the distributor of this product, has been given notice of product recall for the particular batch number P390A262 due to failure to pass bacterial endotoxin testThe use of this product should be stopped immediately.

Therefore, all clinical areas keeping the stocks for this product are required to do prompt checking on the batch number of the current stocks. Kindly segregate the affected stocks according to the batch number and send to Inpatient Pharmacy for exchange of stocks.

New Medication: Tenofovir 300mg/Emtricitabine 200mg/Efavirenz 600mg Tablet

posted Aug 28, 2019, 6:14 PM by Muhammad Fikree Ahmad   [ updated Aug 29, 2019, 1:52 AM ]

Based on the outcome of Drug and Therapeutics Subcommittee Meeting (No. 4/2018), the following medication has been accepted to be in UMMC Formulary.


Product Name

:

Viraday

Active Ingredient

:

Tenofovir 300mg/Emtricitabine 200mg/Efavirenz 600mg

Dosage Form

:

Tablet

Registration No.

:

MAL13065053AZ

Holder

:

Cipla Malaysia Sdn. Bhd.

Manufacturer

:

Cipla Ltd., India

Formulary Category

:

Standard

Prescriber

:

Infectious Disease Specialists

Restrictions

:

First line antiretroviral treatment

Medication Brand Change: Influenza Vaccine

posted Jun 11, 2019, 11:30 PM by Muhammad Fikree Ahmad   [ updated Jun 11, 2019, 11:40 PM ]

4 June 2019 (Circular No. SP PPUM: 241/2019)

Please be informed that Pharmacy Department has replaced the brand for the Influenza vaccine from FluQuadri to Vaxigrip Tetra.
 

Product Name

:

Vaxigrip Tetra

Active Ingredient

:

Influenza Vaccine Type A & B (Inactivated)

Dosage Form

:

Injection

Registration No.

:

MAL18086125ARZ

Holder

:

Sanofi-Aventis (Malaysia) Sdn. Bhd.

Manufacturer

:

Sanofi Pasteur

Formulary Category

:

Special

Prescriber

:

Respiratory Medicine Specialists



Difference between FluQuadri and Vaxigrip Tetra:

Influenza Vaccine

FluQuadri

Vaxigrip Tetra

Manufacturing Country

France 

USA

Formulation

Syringe with needle

Syringe without needle

Population

> 3 years 

> 6 months

1-10 of 96